These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34310976)

  • 1. Neuroinflammation in autism spectrum disorders: Exercise as a "pharmacological" tool.
    Toscano CVA; Barros L; Lima AB; Nunes T; Carvalho HM; Gaspar JM
    Neurosci Biobehav Rev; 2021 Oct; 129():63-74. PubMed ID: 34310976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.
    Bilbo SD; Block CL; Bolton JL; Hanamsagar R; Tran PK
    Exp Neurol; 2018 Jan; 299(Pt A):241-251. PubMed ID: 28698032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Phytochemicals as Neurotherapeutics for Autism Spectrum Disorder: Plausible Mechanism and Evidence.
    Bhandari R; Paliwal JK; Kuhad A
    Adv Neurobiol; 2020; 24():615-646. PubMed ID: 32006377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?
    Gładysz D; Krzywdzińska A; Hozyasz KK
    Mol Neurobiol; 2018 Aug; 55(8):6387-6435. PubMed ID: 29307081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation.
    Ohja K; Gozal E; Fahnestock M; Cai L; Cai J; Freedman JH; Switala A; El-Baz A; Barnes GN
    Neuromolecular Med; 2018 Jun; 20(2):161-173. PubMed ID: 29691724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies.
    Pistollato F; Forbes-Hernández TY; Calderón Iglesias R; Ruiz R; Elexpuru Zabaleta M; Cianciosi D; Giampieri F; Battino M
    Pharmacol Res; 2020 Feb; 152():104579. PubMed ID: 31790820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol: a randomized controlled trial study on the effect of a game-based exercise training program on promoting physical fitness and mental health in children with autism spectrum disorder.
    Yu CCW; Wong SWL; Lo FSF; So RCH; Chan DFY
    BMC Psychiatry; 2018 Feb; 18(1):56. PubMed ID: 29486750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD).
    Hughes HK; R J Moreno ; Ashwood P
    Brain Behav Immun; 2023 Feb; 108():245-254. PubMed ID: 36494048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune related factors in pathogenesis of autism spectrum disorders.
    Szachta P; Skonieczna-Żydecka K; Adler G; Karakua-Juchnowicz H; Madlani H; Ignyś I
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3060-72. PubMed ID: 27460736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
    Thom RP; Keary CJ; Palumbo ML; Ravichandran CT; Mullett JE; Hazen EP; Neumeyer AM; McDougle CJ
    Psychopharmacology (Berl); 2019 Oct; 236(10):3045-3061. PubMed ID: 31139876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune system and autism spectrum disorder: association and therapeutic challenges.
    Heidari A; Rostam-Abadi Y; Rezaei N
    Acta Neurobiol Exp (Wars); 2021; 81(3):249-263. PubMed ID: 34672295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders.
    Liu Q; Chen MX; Sun L; Wallis CU; Zhou JS; Ao LJ; Li Q; Sham PC
    World J Stem Cells; 2019 Feb; 11(2):55-72. PubMed ID: 30842805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epigenetics' implication in autism spectrum disorders: A review].
    Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
    Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental microglial priming in postmortem autism spectrum disorder temporal cortex.
    Lee AS; Azmitia EC; Whitaker-Azmitia PM
    Brain Behav Immun; 2017 May; 62():193-202. PubMed ID: 28159644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder.
    Wang Y; Li N; Yang JJ; Zhao DM; Chen B; Zhang GQ; Chen S; Cao RF; Yu H; Zhao CY; Zhao L; Ge YS; Liu Y; Zhang LH; Hu W; Zhang L; Gai ZT
    Pharmacol Res; 2020 Jul; 157():104784. PubMed ID: 32305492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of Neuroinflammation and Encephalitis in Autism.
    Kern JK; Geier DA; Sykes LK; Geier MR
    Front Cell Neurosci; 2015; 9():519. PubMed ID: 26834565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    Bjorklund G; Saad K; Chirumbolo S; Kern JK; Geier DA; Geier MR; Urbina MA
    Acta Neurobiol Exp (Wars); 2016; 76(4):257-268. PubMed ID: 28094817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia as possible therapeutic targets for autism spectrum disorders.
    Andoh M; Ikegaya Y; Koyama R
    Prog Mol Biol Transl Sci; 2019; 167():223-245. PubMed ID: 31601405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein.
    Dipasquale V; Cutrupi MC; Colavita L; Manti S; Cuppari C; Salpietro C
    Int J Mol Cell Med; 2017; 6(3):148-155. PubMed ID: 29682486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.